Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Sancetta · SciRah

Researcher profile · Semantic Scholar

R. Sancetta

Share profile

R. Sancetta — researcher profile on SciRah

h-index: 22
Works: 74
Citations: 1,800

Most-cited papers

Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis.
C. Agostini, L. Trentin, M. Facco, R. Sancetta +7 more
1996Journal of Immunology185 citations
Semantic Scholar
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
A. Gallamini, L. Rigacci, F. Merli, L. Nassi +16 more
2006Haematologica174 citations
Semantic Scholar
Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
R. Zambello, M. Facco, L. Trentin, R. Sancetta +9 more
1997Blood126 citations
Semantic Scholar
Positron emission tomography in the staging of patients with Hodgkin’s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi
L. Rigacci, U. Vitolo, L. Nassi, F. Merli +13 more
2007Annals of Hematology104 citations
Semantic Scholar
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study.
S. Soverini, L. Bavaro, C. De Benedittis, M. Martelli +45 more
2019Blood101 citations Open access
Semantic Scholar
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
L. Trentin, R. Zambello, R. Sancetta, M. Facco +8 more
1997Cancer Research101 citations
Semantic Scholar
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.
M. Baccarani, E. Abruzzese, V. Accurso, F. Albano +57 more
2019Blood Advances81 citations Open access
Semantic Scholar
Burkitt lymphoma in adolescents and young adults: management challenges
Massimo Dozzo, F. Carobolante, P. Donisi, A. Scattolin +4 more
2016Adolescent Health, Medicine and Therapeutics79 citations Open access
Semantic Scholar
Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease.
C. Agostini, R. Zambello, R. Sancetta, Andrea Cerutti +6 more
1996American Journal of Respiratory and Critical Care Medicine63 citations
Semantic Scholar
Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome.
C. Agostini, L. Trentin, R. Sancetta, M. Facco +7 more
1997Blood58 citations Open access
Semantic Scholar
The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity.
Andrea Cerutti, L. Trentin, R. Zambello, R. Sancetta +5 more
1996Journal of Immunology58 citations Open access
Semantic Scholar
Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes.
R. Zambello, T. P. Loughran, L. Trentin, P. Pontisso +6 more
1995Leukemia53 citations
Semantic Scholar
Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes.
R. Zambello, L. Trentin, M. Facco, Andrea Cerutti +6 more
1995Cancer Research49 citations
Semantic Scholar
Current and future management of Ph/BCR-ABL positive ALL
E. Maino, R. Sancetta, P. Viero, S. Imbergamo +3 more
2014Expert Review of Anticancer Therapy46 citations
Semantic Scholar
Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes.
L. Trentin, R. Zambello, M. Facco, R. Sancetta +2 more
1997Leukemia and Lymphoma43 citations
Semantic Scholar
Selection of T lymphocytes bearing limited TCR-Vbeta regions in the lung of hypersensitivity pneumonitis and sarcoidosis.
L. Trentin, R. Zambello, M. Facco, C. Tassinari +9 more
1997American Journal of Respiratory and Critical Care Medicine39 citations Open access
Semantic Scholar
Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-
A. Gallamini, M. Hutchings, L. Rigacci, L. Specht +14 more
200738 citations
Semantic Scholar
Expression of TNF receptors by T cells and membrane TNF-alpha by alveolar macrophages suggests a role for TNF-alpha in the regulation of the local immune responses in the lung of HIV-1-infected patients.
C. Agostini, R. Zambello, L. Trentin, Andrea Cerutti +6 more
1995Journal of Immunology37 citations
Semantic Scholar
Alveolar macrophages as a cell source of cytokine hyperproduction in HIV‐related interstitial lung disease
C. Agostini, R. Sancetta, A. Cerutti, G. Semenzato
1995Journal of Leukocyte Biology33 citations
Semantic Scholar
Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection.
C. Agostini, Fausto Adami, L. W. Poulter, D. Israel-Biet +9 more
1997American Journal of Respiratory and Critical Care Medicine26 citations
Semantic Scholar
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia.
R. Bassan, T. Intermesoli, A. Scattolin, P. Viero +8 more
2017Clinical Lymphoma, Myeloma & Leukemia23 citations
Semantic Scholar
Skewing of the T‐cell receptor repertoire in the lung of patients with HIV‐1 infection
L. Trentin, R. Zambello, M. Facco, R. Sancetta +7 more
1996AIDS (London)23 citations
Semantic Scholar
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report
M. Breccia, E. Abruzzese, V. Accurso, I. Attolico +45 more
2021British Journal of Haematology22 citations Open access
Semantic Scholar
Lung lymphocytes: origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders.
G. Semenzato, Michela Bortolin, M. Facco, C. Tassinari +3 more
1996Critical reviews in clinical laboratory sciences22 citations
Semantic Scholar
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study
M. Malagola, A. Iurlo, E. Abruzzese, M. Bonifacio +28 more
2021Cancer Medicine20 citations Open access
Semantic Scholar
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients
M. Tiribelli, M. Bonifacio, G. Binotto, A. Iurlo +21 more
2018OncoTarget18 citations Open access
Semantic Scholar
Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts
L. Lanino, F. Restuccia, Alessandra Perego, M. Ubezio +61 more
2023American journal of hematology/oncology16 citations Open access
Semantic Scholar
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice
F. Zaja, M. Mian, S. Volpetti, C. Visco +15 more
2013American journal of hematology/oncology16 citations Open access
Semantic Scholar
Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
L. Trentin, G. Pizzolo, R. Zambello, C. Agostini +6 more
1995Leukemia14 citations
Semantic Scholar
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.
M. Tiribelli, M. Bonifacio, E. Calistri, G. Binotto +9 more
2013Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis12 citations
Semantic Scholar
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL.
L. Scarfò, S. Heltai, E. Albi, E. Scarano +17 more
2022Blood10 citations Open access
Semantic Scholar
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group
G. Rigolin, A. Frustaci, A. Piciocchi, A. Visentin +42 more
2020Hematological Oncology10 citations Open access
Semantic Scholar
Mediterranean Journal of Hematology and Infectious Diseases Modern Immunotherapy of Adult B-lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells
E. Maino, A. Scattolin, P. Viero, R. Sancetta +3 more
10 citations
Semantic Scholar
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
M. Malagola, A. Iurlo, C. Bucelli, E. Abruzzese +26 more
2024Clinical Lymphoma, Myeloma & Leukemia9 citations Open access
Semantic Scholar
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML
M. Tiribelli, R. Latagliata, M. Breccia, I. Capodanno +37 more
2023Cancer9 citations Open access
Semantic Scholar
Real‐World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi‐Resistant Chronic‐Phase Chronic Myeloid Leukemia (CML‐CP) Patient Population
M. Breccia, A. Rossi, V. Giai, B. Martino +42 more
2025Hematological Oncology8 citations Open access
Semantic Scholar
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study
A. Visentin, V. Nasillo, M. Marchetti, Isacco Ferrarini +16 more
2020HemaSphere7 citations Open access
Semantic Scholar
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
E. Crisà, D. Cilloni, Marta Riva, Enrico Balleari +34 more
2025Cancers6 citations Open access
Semantic Scholar
Selection of Valpha 2.3 cells in the lung of patients with sarcoidosis.
Andrea Cerutti, L. Trentin, R. Zambello, Pietro Bulian +6 more
1993Sarcoidosis6 citations
Semantic Scholar
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia
A. Piccin, M. Steurer, M. Mitterer, E. Blöchl +25 more
2015Internal and Emergency Medicine5 citations Open access
Semantic Scholar
Human Immunodeficiency Virus and the Lung
C. Agostini, R. Sancetta, G. Semenzato
19985 citations
Semantic Scholar
P686: REAL-WORLD EFFICACY PROFILE OF ASCIMINIB IN AN ITALIAN, MULTI-RESISTANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENT POPULATION
M. Breccia, A. R. Russo Rossi, V. Giai, B. Martino +42 more
2023HemaSphere4 citations Open access
Semantic Scholar
Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study
L. Scarfò, S. Heltai, E. Albi, E. Scarano +17 more
2020Blood4 citations Open access
Semantic Scholar
Compound BCR-ABL1 Kinase Domain Mutants: Prevalence, Spectrum and Correlation with Tyrosine Kinase Inhibitor Resistance in a Prospective Series of Philadelphia Chromosome-Positive Leukemia Patients Analyzed By Next Generation Sequencing
S. Soverini, L. Bavaro, M. Martelli, C. De Benedittis +43 more
2018Blood4 citations
Semantic Scholar
IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease
L. Rigacci, P. Zinzani, Benedetta Puccini, A. Broccoli +17 more
20104 citations
Semantic Scholar
Choice of Frontline Tyrosine‐Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A “Campus CML” Study
C. Bucelli, I. Capodanno, M. C. Miggiano, F. Cavazzini +38 more
2024European Journal of Haematology3 citations Open access
Semantic Scholar
Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study
E. Albi, L. Scarfò, S. Heltai, E. Scarano +20 more
2023Blood3 citations Open access
Semantic Scholar
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY
M. Malagola, F. Efficace, N. Polverelli, F. Cottone +33 more
2019HemaSphere3 citations Open access
Semantic Scholar
The pediatric rhabdomyosarcoma translocation (2;13)(q35;q14) in B-prolymphocytic leukemia.
Fausto Adami, R. Sancetta, L. Trentin, G. Semenzato +3 more
1993Leukemia3 citations
Semantic Scholar
P646: VENETOCLAX RETREATMENT AFTER MRD-GUIDED VENETOCLAX +/- IBRUTINIB: THE IMPROVE STUDY COHORT
L. Scarfò, S. Heltai, E. Albi, E. Scarano +20 more
2023HemaSphere2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Trentin×19
Invite
L. Trentin — researcher profile on SciRah
G. Semenzato×17
Invite
G. Semenzato — researcher profile on SciRah
C. Agostini×15
Invite
C. Agostini — researcher profile on SciRah
R. Zambello×14
Invite
R. Zambello — researcher profile on SciRah

×13

Invite

G. Binotto — researcher profile on SciRah

Invite

M. Facco — researcher profile on SciRah

Invite

A. Iurlo — researcher profile on SciRah

M. Bonifacio×11

Invite

M. Bonifacio — researcher profile on SciRah

Invite

F. Stagno — researcher profile on SciRah

M. Tiribelli×10

Invite

M. Tiribelli — researcher profile on SciRah

Andrea Cerutti×9

Invite

Andrea Cerutti — researcher profile on SciRah

C. Tassinari×9

Invite

C. Tassinari — researcher profile on SciRah